Skip to content
A5032Assembly2021-2022 SessionSame asS5901

Protect Access to Brand Drugs

Official title

“Relates to coverage for single source drugs”

Sponsor Philip RamosAD-6Affects Finance
Status
In Assembly Committee
Insurance
Impact
6/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Insurance

What's happening

This bill requires insurance policies to continue covering single source drugs during formulary changes if a patient files an appeal or grievance.

Why it matters

  1. Protects continuity of care. for patients who rely on single source (brand name, no generic) drugs, ensuring they don't lose coverage during insurance formulary changes if they actively appeal or file a grievance.

  2. Reduces financial and health risks. by requiring insurers to maintain the same coverage terms for these drugs until the appeal or grievance is resolved, preventing sudden out-of-pocket costs or forced medication changes.

  3. Empowers patients. by giving them a clear mechanism to contest formulary removals without immediate loss of drug coverage, which can be crucial for those with complex or rare conditions.

  4. Limits insurer discretion. in dropping coverage for high-cost, single source drugs, potentially impacting how insurers manage drug formularies and negotiate with pharmaceutical companies.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Patients taking brand-name drugs with no generic equivalent

    Those whose covered drug is removed from or loses preferred status on a formulary would retain coverage on the same terms while a filed grievance or appeal is pending.

  • Health insurers and HMOs

    The bill would require covered policies and contracts to preserve coverage for qualifying single-source drugs until a final grievance or appeal decision.

  • State and federal agencies handling coverage appeals

    A grievance or appeal filed with these agencies or their designees would trigger continued coverage for qualifying patients until a final decision.

Headline styles

Protect Access to Brand Drugs

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Philip Ramos

Assembly Member · Assembly District 6

No co-sponsors yet.

History

  1. Referred to insurance
  2. Referred to insurance

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

S5901Senate

Protect Access to Brand Drugs

In Senate Committee · Insurance · Sponsor Kevin S. Parker

Impact 6 · Moderate0% to pass

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

5032

2021-2022 Regular Sessions

IN ASSEMBLY

February 10, 2021

Introduced by M. of A. RAMOS -- read once and referred to the Committee on Insurance

AN ACT to amend the insurance law, in relation to coverage for single source drugs

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 36 to read as follows:

(36) Every individual or blanket policy delivered or issued for delivery in this state providing coverage for prescription drugs through the use of a drug formulary shall include a provision which, in the event of a change to such formulary, allows a covered person who is taking a single source drug covered under such policy that is no longer included in or preferred under such formulary and has filed a grievance or an appeal of the denial of access to the drug with the insurer or a state or federal agency or designee of such agency, to continue receiving coverage for such drug under the same terms and conditions as would apply under the policy were such drug still included in or preferred under the formulary, until a final decision is rendered on the appeal or grievance. For the purpose of this paragraph, "single source drug" means a brandname drug for which there is no generic equivalent.

§ 2. Subsection (k) of section 3221 of the insurance law is amended by adding a new paragraph 22 to read as follows:

(22) Every group or blanket policy delivered or issued for delivery in this state providing coverage for prescription drugs through the use of a drug formulary shall include a provision which, in the event of a change to such formulary, allows a covered person who is taking a single source drug covered under such policy that is no longer included in or preferred under such formulary and has filed a grievance or an appeal of the denial of access to the drug with the insurer or a state or federal agency or designee of such agency, to continue receiving coverage for

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD07901-01-1

A. 5032 2

such drug under the same terms and conditions as would apply under the policy were such drug still included in or preferred under the formulary, until a final decision is rendered on the appeal or grievance. For the purpose of this paragraph, "single source drug" means a brandname drug for which there is no generic equivalent.

§ 3. Section 4303 of the insurance law is amended by adding a new subsection (ss) to read as follows:

(ss) Every contract delivered or issued for delivery in this state providing coverage for prescription drugs through the use of a drug formulary shall include a provision which, in the event of a change to such formulary, allows a covered person who is taking a single source drug covered under such contract that is no longer included in or preferred under such formulary and has filed a grievance or an appeal of the denial of access to the drug with the insurer corporation or organization certified pursuant to article forty-four of the public health law or a state or federal agency or designee of such agency, to continue receiving coverage for such drug under the same terms and conditions as would apply under the contract were such drug still included in or preferred under the formulary, until a final decision is rendered on the appeal or grievance. For the purpose of this subsection, "single source drug" means a brandname drug for which there is no generic equivalent.

§ 4. This act shall take effect on the first of the calendar month next succeeding the sixtieth day after it shall have become a law; provided, however, that this act shall apply only to policies and contracts issued, renewed or amended on or after such effective date.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.